World Equity Group, Inc. Bristol Myers Squibb CO Transaction History

World Equity Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 22, 2024	SELL	$48.48 - $57.85 $200,998 - $239,846	-4,146 Closed	0 $0
Q3 2023 Jul 22, 2024	BUY	$57.89 - $64.73 $240,011 - $268,370	4,146 New	4,146 $241 Million
Q2 2023 Aug 26, 2024	SELL	$63.71 - $70.74 $476,869 - $529,488	-7,485 Closed	0 $0
Q1 2023 Aug 26, 2024	BUY	$65.71 - $74.53 $491,839 - $557,857	7,485 New	7,485 $255 Million
Q2 2022 Sep 06, 2024	SELL	$72.62 - $79.98 $92,808 - $102,214	-1,278 Reduced 31.79%	2,742 $211 Million
Q1 2022 Sep 06, 2024	BUY	$61.48 - $73.72 $247,149 - $296,354	4,020 New	4,020 $294 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.